A new consumer poll by NuggMD shows that a majority of frequent cannabis consumers have increased their spending on cannabis products in the past year, with 45 percent expecting their spending to rise further in the next year. The data suggests a strong and growing demand for cannabis products. Head of communications, Andrew Graham, believes the demand for cannabis is durable and likely to increase even more.
Alleaves and BioTrack have partnered with the New York Cannabis Retail Association to offer advanced technology solutions for cannabis retailers in New York. BioTrack's traceability system ensures compliance, while Alleaves provides point-of-sale systems and payment processing. The partnership aims to support retailers in the state's expanding cannabis market, with NYCRA offering members access to management tools and educational events.
In this episode, we discuss the launch of CannaBlendz, the world's first cannabis enhancer, in New York. These adaptogen-packed gummies are designed to enhance the effects of cannabis naturally, targeting specific receptors in the central nervous system to promote focus, recovery, performance, and motivation. With benefits like reduced social anxiety and increased stamina, CannaBlendz products are now available at licensed dispensaries across NYC.
Join us for a special episode covering the 7th Annual Hamptons Cannabis Event, focusing on 'Psychedelics & Cannabis in Chronic Disease Management: Integrative Medicine Approaches.' Taking place on August 1, 2024, at the Shinnecock Nations dispensary in Southampton, NY, this event aims to reshape the future of medical cannabis and psychedelics. Key participants like Tremaine S. Wright and Dr. Natanya Wachtel will discuss regulatory developments and integrative approaches for chronic disease management, offering valuable insights for attendees.
In this episode, we discuss the surge in popularity of edibles containing minor cannabinoids in the market. Recent data from BayMedica shows a 47 percent year-over-year growth, reaching $391 million in sales. Minor cannabinoids like CBC, THCV, CBDV, and CBN offer unique therapeutic benefits, leading to a 6.3 percent higher average item price for brands incorporating them. The future of edibles lies in strategically integrating these minor cannabinoids to meet evolving consumer needs for holistic well-being.
Join us as we dive into Ascend Wellness CEO John Hartman's discussion on the company's growth strategy and market expansion plans. With a strong presence in the Midwest, Northeast, and Mid-Atlantic regions, Ascend Wellness is focusing on maximizing dispensaries in select markets to drive growth. Hartman's expertise in wholesale, retail, and manufacturing is being leveraged to deploy capital and pursue mergers and acquisitions, including a recent refinancing of a term loan for enhanced financial stability.
Nevis Brands CEO John Kueber discusses the company's strong financial results for Q2 2024, reporting cannabis beverage royalty revenues of $436,532 and a Gross Profit of $291,392. Kueber highlights the 15 percent increase over the previous quarter, expansion in active states, and plans for product line development. The company aims to introduce new products in existing markets in 2024 for continued growth.
Join us as we discuss the recent poll results from NuggMD, revealing Lava Cake as the top cannabis strain among consumers. With effects like pain relief, anxiety relief, and stress relief being the most popular preferences, Lava Cake stands out for its combination of flavors and benefits. The poll also highlights a growing trend of using cannabis for managing stress and anxiety.
Join us as we dive into the exciting return of the iconic cannabis brand Brass Knuckles to the California market in the summer of 2024. Co-Founder Mike Healy highlights the brand's dedication to community empowerment and authenticity, partnering with Lucid Green to ensure consumer trust with unique identifiers on every product. Discover Brass Knuckles' California roots, quality commitment, and innovative offerings as they expand to new markets by the end of 2024, offering pure empowerment with no gimmicks or BS.